Zobrazeno 1 - 6
of 6
pro vyhledávání: '"N. A. Ananicheva"'
Autor:
O. A. Kupriushina, D. A. Strelkova, A. S. Yasneva, S. A. Rachina, S. N. Avdeev, A. E. Vlasenko, L. V. Fedina, O. V. Ivanova, I. V. Kaledina, N. A. Ananicheva
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 78-85 (2024)
Relevance. During and after the COVID-19 pandemic, viruses have become a more common cause of pulmonary infections in adults; therefore, the distinction between viral lung injury and community-acquired bacterial pneumonia is of increasing importance.
Externí odkaz:
https://doaj.org/article/96be733286ee41cfbe6ebb0051e56f30
Autor:
K. V. Charaya, D. Yu. Shchekochikhin, S. N. Tarasenko, N. A. Ananicheva, S. A. Sovetova, T. V. Soboleva, O. N. Dikur, A. I. Borenstein, D. A. Andreev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 6, Pp 656-661 (2023)
Aim. To analyze the clinical significance of the sodium level in a single urine test obtained 2 hours after the first dose of a loop diuretic was administered in patients with acute decompensation of chronic heart failure (ADHF).Material and methods.
Externí odkaz:
https://doaj.org/article/d49b07062e5a47a19594f63858bdb604
Autor:
A. Yu. Lebedeva, O. M. Koteshkova, O. N. Dzhioeva, S. R. Gilyarevsky, T. M. Uskach, M. S. Novikova, Ya. A. Orlova, V. Yu. Kalashnikov, D. V. Privalov, N. A. Ananicheva, M. Yu. Gilyarov, A. D. Erlikh
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 1, Pp 165-168 (2021)
The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of emp
Externí odkaz:
https://doaj.org/article/8642d167fac5420cbea6c65fee3a0b3e
Autor:
S. Ye. Gratsianakaya, O. A. Arkhipova, A. I. Davydov, T. V. Martynyuk, N. A. Ananicheva, O. S. Belkorey, I. Ye. Chazova
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 72-81 (2018)
A patient with pulmonary arterial hypertension (PAH) associated with congenital heart disease (ventricular septal defect) and Eisenmenger syndrome was started on an endothelin receptor antagonist bosentan. With treatment, the patient's condition had
Externí odkaz:
https://doaj.org/article/6934484f37a045428f1a88b4e05ca44b
Autor:
N A Ananicheva, M. Yu. Gilyarov, T. M. Uskach, M. S. Novikova, A. Yu. Lebedeva, A. D. Erlikh, Ya A Orlova, S. R. Gilyarevsky, V. Yu. Kalashnikov, O. N. Dzhioeva, D. V. Privalov, O. M. Koteshkova
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 1, Pp 165-168 (2021)
The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of emp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb6fea71a9cbe00da28669508d4b70d6
https://doi.org/10.20996/1819-6446-2021-01-03
https://doi.org/10.20996/1819-6446-2021-01-03
Autor:
M. Yu. Gilyarov, N A Ananicheva, Denis Andreev, D Yu Shchekochihin, O. A. Baturina, D. A. Sychev, Abram Syrkin
Publikováno v:
Kardiologiia. 59:40-48
Purpose:To assess the prevalence of atrial fibrillation (AF) and use of antithrombotic agents in adult patients with acute coronary syndrome (ACS).Materials and Methods.We consecutively enrolled all ACS patients (n=1155) who were hospitalized in two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2658de6f501c8c282b0837a5d74b3a00
https://doi.org/10.18087/cardio.2019.1.10213
https://doi.org/10.18087/cardio.2019.1.10213